10 March 2006
A new, publicly accessible resource, the Genetic Association Information Network (GAIN) has been launched this month. The network is a public-private partnership of the Foundation for the National Institutes of Health, Inc (FNIH), a venture between the US National Institutes of Health (NIH) and Pfizer Global Research & Development. The Network is intended to include academic centres, corporations, private foundations, advocacy groups and philanthropists, and is seeking funding from such groups.
Its aim is to advance understanding of the genetic factors that influence risk of common, complex diseases such as diabetes, asthma, depression and cardiovascular disease, via whole genome association studies using samples from existing case-control studies of common diseases. It is hoped that this information will be of value in developing preventative, diagnostic and therapeutic strategies for disease. Specifically, GAIN is